Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Musculoskeletal | Rheumatology

Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

California

Cedars Sinai Medical Center Cedars Sinai 4
Los Angeles California 90048

A Phase 4 clinical study for patients using Pasireotide

Cedars-Sinai Medical Center
Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Massachusetts General Hospital
Boston Massachusetts 02114

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

Michigan

University of Michigan Comprehensive Cancer Center SC-2
Ann Arbor Michigan 48109-0944

A Phase 4 clinical study for patients using Pasireotide

New Jersey

Ipsen
Basking Ridge New Jersey 07920

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

Washington

Swedish Cancer Institute Swedish Cancer Institute (SC)
Seattle Washington 98104

A Phase 4 clinical study for patients using Pasireotide

Austria

University Hospital of Vienna
Vienna

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Belgium

Novartis Investigative Site
Brugge 8310

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Bruxelles 1200

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Edegem 2650

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Leuven 3000

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Liege 4000

A Phase 4 clinical study for patients using Pasireotide

Canada

Novartis Investigative Site
Halifax Nova Scotia B3H 1V7

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
London Ontario N6A 4L6

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Montreal Quebec H2L 4M1

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Montreal H2W 1T8

A Phase 4 clinical study for patients using Pasireotide

CHUM - Notre-Dame Hospital
Montreal Quebec H2L 4M1

Patients are needed to participate in a clinical research study evaluating Alesse for the treatment of Acromegaly

France

Novartis Investigative Site
Angers 49033

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Bron Cedex 69677

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Le Kremlin Bicetre 94275

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Pierre-Benite Cedex 69495

A Phase 4 clinical study for patients using Pasireotide

Toulouse

A clinical trial seeking patients for a research study for the treatment of Acromegaly

View More »

Novartis Investigative Site
Toulouse Cedex 9 31059

A Phase 4 clinical study for patients using Pasireotide

Germany

ENDOC
Hamburg 20357

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Novartis Investigative Site
Muenchen 80804

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
München 80336

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Ulm 89081

A Phase 4 clinical study for patients using Pasireotide

University of Wuerzburg, Department of Endocrinology
Wuerzburg Bavaria 97080

A clinical trial seeking patients for a research study for the treatment of Acromegaly, Heart Failure or Hypertrophy, Left Ventricular

View More »

Novartis Investigative Site
Würzburg 97080

A Phase 4 clinical study for patients using Pasireotide

Italy

Novartis Investigative Site
Ancona AN 60126

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Milano MI 20149

A Phase 4 clinical study for patients using Pasireotide

Novartis Investigative Site
Padova PD 35128

A Phase 4 clinical study for patients using Pasireotide

Japan

Novartis Investigative Site
Bunkyo-ku Tokyo 113-8655

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Bunkyo-ku Tokyo 113-8603

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Chiba-city Chiba 260-8677

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Isehara-city Kanagawa 259-1193

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Kagoshima-city Kagoshima 890-8520

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

View More »

Novartis Investigative Site
Kitakyushu Fukuoka 807-8556

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Kobe-city Hyogo 650-0017

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Kyoto-city Kyoto 612-8555

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Maebashi-city Gunma 371-8511

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Minato-ku Tokyo 105-8470

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Morioka-city Iwate 020-8505

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Nagoya-city Aichi 466-8560

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Sapporo-city Hokkaido 060-8648

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Shinjuku-ku Tokyo 162-8666

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Shizuoka 420-8527

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Suita-city Osaka 565-0871

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

Novartis Investigative Site
Yamagata 990-9585

Patients are needed to participate in a clinical research study of SOM230LAR to evaluate Acromegaly, Pituitary Gigantism

First 1 2 Last